Peptide-based Antifungal Therapies against Emerging Infections.
about
An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosisDiscovery of Short Peptides Exhibiting High Potency against Cryptococcus neoformansSynthetically modified L-histidine-rich peptidomimetics exhibit potent activity against Cryptococcus neoformansEnhancement of antifungal activity by integrin-targeting of branched histidine rich peptides.Biochemical characterization of an anti-Candida factor produced by Enterococcus faecalisThe anti-Candida activity by Ancillary Proteins of an Enterococcus faecium strain.Activity of Novel Synthetic Peptides against Candida albicans.Discovery and Characterization of a Peptoid with Antifungal Activity against Cryptococcus neoformans.Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae)Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs.In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies.Current trends in outwitting resistance development in Candida infections through photodynamic and short peptide therapies: a strategic-shift from conventional antifungal agents.Anti-fungal activity of Ctn[15-34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin.Natural and synthetic peptides with antifungal activity.Skin Immunity.Candida biofilms and the host: models and new concepts for eradicationFirst Total Synthesis and Biological Screening of a Proline-Rich Cyclopeptide from a Caribbean Marine Sponge.Recent Developments in Antimicrobial Polymers: A Review.Antifungal activity in vitro and in vivo of a salmon protamine peptide and its derived cyclic peptide against Candida albicans.Chemical synthesis, structure-activity relationship, and properties of shepherin I: a fungicidal peptide enriched in glycine-glycine-histidine motifs.The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections.Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency.Structural properties of bioactive peptides with α-glucosidase inhibitory activity.Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.PepBio: predicting the bioactivity of host defense peptidesProteomics assisted profiling of antimicrobial peptide signatures from black pepper (Piper nigrum L.).Majocchi's granuloma: current perspectives.Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics.
P2860
Q28534020-0EA114D2-AF0D-484D-867C-6F69C1A5C5AFQ33636123-784ACE5A-9A22-45B5-9DBD-8D7AB533D89BQ33787558-02D8B008-7323-4087-A5DC-F9848A8D28A5Q33811522-AE588FF2-1A4F-446F-80EC-C97EB0863876Q34325020-301EA51F-4845-42D7-ABDF-8DEF757492C3Q35584987-DE86ECAD-EAF2-4244-A5F2-AE362AA5A886Q36154522-66A1F62C-52C9-4A30-8D59-87ECBF6FD6B7Q36229042-23C76536-EDD5-4ADA-A2B2-05101A0072AFQ36608221-907D433F-2541-497E-A466-B84DFF726BD6Q37909413-7E5BC6F5-0BB2-4D64-9F00-38B2C4F0E9C1Q38378762-BDA04759-93A3-49CB-9F0F-92027D3BBF4DQ38715450-810DA078-6767-4593-AF8C-7D377521A4DBQ38729566-31A2CA40-5071-44AF-A42D-36C7149F63CFQ38833324-A729FB23-588E-4C90-AC99-883017AC6FDCQ39379300-CA8FE573-F45E-41D6-B118-686E4FFBAA3CQ39490081-FA26B716-D748-442C-8704-1F823BE37B34Q40046017-5792218B-5341-4470-A6F2-C08F1E72474CQ40107966-3ADF9FBE-E268-4DC6-B40D-2D35CCB97505Q40424835-E076976D-A4E2-4F1E-B7A8-F6D3A70545E2Q46854807-06148425-6627-4431-AF5C-0BE685744609Q47196341-A117EF5B-6798-48BC-ADA0-B0A96FEA6B26Q47343575-05B4ED67-4B5A-43CE-9F66-CC787C0F8115Q48104797-187B9184-82A9-4BAE-ACEF-749250DDF161Q48163141-52A9C60A-D1C3-4FF9-AF3C-5FC279990792Q51960837-BAE7D1AA-3222-47B0-B5B1-462CEF07ACFFQ52564767-30A5FCCB-34C9-4699-A36B-4EA7B8A13BDEQ54989626-145E010F-AA0D-4C19-BFA9-804D487D1E7DQ55424061-257FC717-F24D-41C8-BCC7-A3341FD57B35
P2860
Peptide-based Antifungal Therapies against Emerging Infections.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Peptide-based Antifungal Therapies against Emerging Infections.
@ast
Peptide-based Antifungal Therapies against Emerging Infections.
@en
type
label
Peptide-based Antifungal Therapies against Emerging Infections.
@ast
Peptide-based Antifungal Therapies against Emerging Infections.
@en
prefLabel
Peptide-based Antifungal Therapies against Emerging Infections.
@ast
Peptide-based Antifungal Therapies against Emerging Infections.
@en
P2093
P2860
P1433
P1476
Peptide-based Antifungal Therapies against Emerging Infections
@en
P2093
P2860
P356
10.1358/DOF.2010.035.03.1452077
P577
2010-03-01T00:00:00Z